12 July

Dr Marg Ewen Receives the Helen Clark-JoPPP Award

4 April

No Universal Health Coverage without Universal Medicines Coverage

18 December

A Year at the Heart of Regulatory Decision Making

31 October

Staff Spotlight: Jaume Vidal

11 October

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

2 October

Medicijnen: de link met de maatschappij

21 February

What Role Can Civil Society Play in the European Regulatory Process?

7 February

Open Science for Health: Shaping the New Framework Programme

14 December

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

27 November

New Dutch Government Must Ensure Transparency to Control Medicine Prices

16 October

Staff Spotlight: Tim Reed

15 February

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

1 December

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

27 July

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

23 February

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

11 December

HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World

28 September

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

9 June

HAI urges MEPs to support key amendments to TTIP resolution

4 February

The EU-US Trade Deal Could Leave Europeans Sick

9 December

More work needed on new EMA conflicts of interest policy

15 October

EMA policy on clinical data publication a step ahead, but falls short of true potential

18 September

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

15 July

School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis

23 June

Setting precedents: EMA must get clinical trial data policy right to truly act in public interest

11 June

HAI Europe calls on EMA's Management Board to stand for data transparency

10 April

Tamiflu review shows desperate need for full clinical trials data transparency

24 February

A new (and improved) model to regulate pharmaceutical promotion

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

25 November

When politicians go to the movies